Coronavirus
CanSino Bio, the first Chinese coronavirus vaccine, arrived in Mexico last November. With 15 thousand volunteers in various states of the Mexican Republic, the Chinese vaccine against Covid-19 began its phase 3 clinical trials. This vaccine, called Ad5-nCoV, has shown a certain degree of safety in phase 2 and phase 3 from previously developed clinical trials in China. Phase 3 studies of the Chinese coronavirus vaccine will be carried out in health centers in 12 states of the country. In case of positive results, the Mexican government will complete a definitive purchase of 35 million doses of the first Chinese coronavirus vaccine.